KELLERMAN DONALD J (VP, Clinical Dev & Med Affairs) received a stock award from ZOSANO PHARMA CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/1/2021ACC: 0001567619-21-007413
Officer· VP, Clinical Dev & Med Affairs
Since Jun 2019
+97.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
97.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+32.50K
Price / share
—
Trade value
—
% of position
166.3%
3/30/2021
19.55K→52.05K
Total
Net shares
+32.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/30/2021 | A · Award | +32.50K | — | — | 166.3% | 19.55K | 52.05K |
| Total | +32.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
65K shares
Shares
+65K
Strike price
1.20
Held after
65K
Exercisable
—
3/30/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock65K shares | 3/30/2021 | A · Award | +65K | 1.20 | — | 65K |